New Kidney Cancer Rx May Improve Survival
A new medication could be a game-changer for treating advanced kidney cancer.
Advancing the War Against Advanced Kidney Cancer
Currently, there’s no standard of care to treat kidney cancer that has spread to other parts of the body. A phase ll trial involving an existing drug may change that.
Stomach Cancer Didn't Respond to Rx
Stomach cancer is relatively rare in the US but common in other parts of the world, particularly in Asia. A recent study evaluated the effectiveness of an existing medication in treating this cancer.
New Treatment for Refractory Epilepsy
Trying to manage seizures in patients with refractory epilepsy — a type of epilepsy where medicine no longer works to control seizures — can be very challenging, but there may be renewed hope.
New Stent Keeps Arteries Unclogged
For patients with heart disease, stents have been a major breakthrough for preventing the narrowing of blood vessels. A new drug-releasing stent helps prevent blocked arteries.
Shrinking Brain Tumors and a Whole Lot More
It started out as a drug to combat organ rejection in transplant patients. Everolimus now has many uses, including treating various types of cancer. And the list of its applications is expanding.
FDA Approves Children's Brain Tumor Drug
The US Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA).
Child’s Dosage Approved For Cancer Rx
A rare type of brain tumor called SEGA ( subependymal giant cell astrocytoma ) can appear in children. The drug designed to take on this cancer is too strong for young patients. Now a new children’s dosage of a medication has been approved.
Powerful Rx Combo for Advanced Breast Cancer
The U.S. Food and Drug Administration has approved a drug to be used for postmenopausal women with advanced hormone-receptor positive and HER2-negative breast cancer.
Afinitor for Non-Cancerous Kidney Tumors
The U.S. Food and Drug Administration approved Afinitor ( everolimus ), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas ) not requiring immediate surgery in patients with tuberous sclerosis complex ( TSC ).